Literature DB >> 6173205

Glucose-dependent insulinotropic action of cholecystokinin and caerulein in the isolated perfused rat pancreas.

C Sakamoto, M Otsuki, A Ohki, H Yuu, M Maeda, T Yamasaki, S Baba.   

Abstract

The effect of pure natural porcine cholecystokinin (CCK) and synthetic caerulein on endocrine and exocrine pancreatic secretion was investigated in the isolated perfused rat pancreas in the presence of physiological concentrations of glucose. CCK (0.25 mU/ml) or caerulein (0.01 ng/ml) potentiated the insulin secretion induced by 5.6 mM glucose; a significant increase in pancreatic exocrine secretion was also observed at these doses of CCK or caerulein. Further increases in the concentration of CCK (0.25 to 1 mU/ml) or caerulein (0.01 to 1 ng/ml) resulted in dose-dependent increases in both insulin and pancreatic exocrine secretion. The effectiveness of CCK and caerulein as insulinotropic agents depended on the glucose concentration; they were more effective at higher concentrations of glucose. Thus, CCK or caerulein significantly and coincidentally stimulated both insulin secretion and pancreatic exocrine function if 5.6 mM or more glucose is present, whereas in previous studies using 2.8 mM glucose, stimulation of insulin secretion was elicited only with concentrations of the peptides supramaximal for an effect on pancreatic exocrine secretion. CCK may contribute to the entero-insular axis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173205     DOI: 10.1210/endo-110-2-398

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Exocrine pancreatic function in rats after acute trypsin inhibitor treatment.

Authors:  M Otsuki; A Ohki; C Sakamoto; Y Okabayashi; S Baba
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

2.  Inhibitory effects of pirenzepine on cholecystokinin and secretin stimulation on exocrine and endocrine rat pancreas.

Authors:  M Otsuki; Y Okabayashi; T Nakamura; M Fujii; T Oka; S Tani; S Baba
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

3.  Effect of chronic oral administration of the CCK receptor antagonist loxiglumide on exocrine and endocrine pancreas in normal rats.

Authors:  I Imoto; M Yamamoto; D M Jia; M Otsuki
Journal:  Int J Pancreatol       Date:  1997-12

4.  Antagonistic effect of dibutyryl cyclic GMP on caerulein induced insulin secretion in isolated perifused rat islets.

Authors:  W Lee; H Wakasugi; A Funakoshi
Journal:  Gastroenterol Jpn       Date:  1988-06

5.  Exocrine and endocrine secretion from isolated perfused rat pancreas with islet cell tumors induced by streptozotocin and nicotinamide.

Authors:  C Sakamoto; M Otsuki; A Ohki; T Kazumi; T Yamasaki; H Yuu; M Maeda; G Yoshino; S Baba
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

6.  Effects of CCK-receptor antagonists on CCK-stimulated pepsinogen secretion and calcium increase in isolated guinea pig gastric chief cells.

Authors:  C Sakamoto; T Matozaki; H Nishisaki; Y Konda; M Nagao; O Nakano
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

7.  Effect of acarbose on exocrine and endocrine pancreatic function in the rat.

Authors:  M Otsuki; C Sakamoto; A Ohki; Y Okabayashi; I Suehiro; S Baba
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

8.  Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man.

Authors:  J Reimers; M Nauck; W Creutzfeldt; J Strietzel; R Ebert; P Cantor; G Hoffmann
Journal:  Diabetologia       Date:  1988-05       Impact factor: 10.122

9.  Cholecystokinin (CCK8) regulates glucagon, insulin, and somatostatin secretion from isolated rat pancreatic islets: interaction with glucose.

Authors:  E J Verspohl; H P Ammon
Journal:  Pflugers Arch       Date:  1987-10       Impact factor: 3.657

10.  Impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice.

Authors:  Chun-Min Lo; Silvana Obici; H Henry Dong; Michael Haas; Dawnwen Lou; Dae Hyun Kim; Min Liu; David D'Alessio; Stephen C Woods; Patrick Tso
Journal:  Diabetes       Date:  2011-05-20       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.